AMSTERDAM — For patients with diffuse cutaneous systemic sclerosis, an autoimmune disease for which there are few treatment options, lenabasum (JBT-101, Corbus Pharmaceuticals) shows potential, new ...

Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.

CD19-targeting chimeric antigen receptor (CAR) T-cell therapy shows potential to intercept fibrotic organ manifestations and improve disease measures in patients with diffuse cutaneous systemic ...

Please provide your email address to receive an email when new articles are posted on . Mycophenolate mofetil outperformed methotrexate, steroids and other immunosuppressives in diffuse cutaneous SSc ...

Q: My daughter, who is 14-years-old, was diagnosed with localized scleroderma about three years ago, and I am finding out that not much is known on this disease. Could you tell be about it? Does it ...

GERMANTOWN, Md., Jan. 30, 2023 /PRNewswire/ -- The HealthWell Foundation ®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, is proud to announce that ...

The therapy is already being evaluated in patients with lupus nephritis and diffuse cutaneous systemic sclerosis. "We have seen firsthand the transformative effects of KYV-101 in MG patients treated ...

Please provide your email address to receive an email when new articles are posted on . Data from two large U.S. cohorts showed more than 30% of patients with SSc demonstrated an initial symptom other ...